Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 36, Issue 4, April 2011, Pages 267-345
 
MONOGRAPHS
 
  
 Briakinumab.
Human anti-IL-12/23 monoclonal antibody, Treatment of psoriasis, Treatment of Crohn's disease.
Crowley, J.J.
Drugs Fut 2011, 36(4): 267
Summary | Full Text: HTMLPDF 
 
  
  
 Fostamatinib disodium.
Tyrosine-protein kinase SYK/FLT3 inhibitor, Treatment of rheumatoid arthritis, Oncolytic.
Tam, F.W.K., McAdoo, S.P.
Drugs Fut 2011, 36(4): 273
Summary | Full Text: HTMLPDF 
 
  
  
 NGR-hTNF.
Vascular targeting agent, Oncolytic.
Vasiliou, S.
Drugs Fut 2011, 36(4): 281
Summary | Full Text: HTMLPDF 
 
  
 
REVIEW ARTICLES
 
  
 Novel therapeutic approaches for glaucoma.
Kaufman, P.L., Rasmussen, C.A.
Drugs Fut 2011, 36(4): 287
Summary | Full Text: HTMLPDF 
 
  
  
 The therapeutic potential of bradykinin B1 receptor antagonists in chronic pain.
Farkas, S., Eles, J.
Drugs Fut 2011, 36(4): 301
Summary | Full Text: HTMLPDF 
 
  
 
FILLING THE GAPS IN DRUG THERAPY
 
  
 Exploring the role of phosphodiesterase PDE5 inhibition in the treatment of muscular dystrophy.
Yasuhara, S.E.
Drugs Fut 2011, 36(4): 321
Summary | Full Text: HTMLPDF 
 
  
 
MEETING REPORT
 
  
 Advances in epilepsy research: 64th Annual Meeting of the American Epilepsy Society, San Antonio, Texas, USA.
Dhir, A.
Drugs Fut 2011, 36(4): 341
Summary | Full Text: HTMLPDF 
 
  
 
  



© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy